8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Sep 29, 2022 · 3y ago · Accession 0000950170-22-018988
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- 8-K
- Filing date
- Sep 29, 2022
- Report date
- Sep 29, 2022
- Document
- glto-20220929.htm
- Size
- 267 KB